Skip to main content
BIO PROTECH INC. logo

BIO PROTECH INC. — Investor Relations & Filings

Ticker · 199290 ISIN · KR7199290008 LEI · 988400TYKP3J6SZOGR02 KO Manufacturing
Open in API
Filings indexed 281 across all filing types
Latest filing 2024-10-07 Director's Dealing
Country KR South Korea
Listing KO 199290

About BIO PROTECH INC.

https://www.protechsite.com/

BIO PROTECH INC. is a manufacturer of medical equipment and disposable supplies. The company develops and produces a range of products for applications in surgery, cardiology, neurology, and pain management. Its portfolio includes electrosurgical devices such as smoke evacuators and surgical pencils, various electrocardiogram (ECG) electrodes, and transcutaneous electrical nerve stimulation (TENS) units. The company specializes in bio-medical sensors and related products developed using advanced skin technology for the global healthcare market.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report insider transactions (share ownership changes) by company directors or major shareholders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2024-10-07 Korean
[기재정정]타법인주식및출자증권취득결정
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from a Korean company (Bio Protech) regarding an amendment to a previous disclosure about the acquisition of shares/securities in another company (BIO PROTECH YANTAI INC.). It details the change in the acquisition date and the status of capital injection. This falls under 'M&A Activity' (TAR) as it relates to investment and capital allocation in another entity, or potentially 'Regulatory Filings' (RNS) as a general corporate announcement. Given the specific nature of the 'acquisition of shares/securities' disclosure, TAR is the most accurate classification.
2024-09-13 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정) and specifically includes a 'Correction Report' (정정신고) header. This document details the terms of convertible bonds, including maturity dates, conversion prices, and interest rates, which falls under the category of capital and financing updates. It is not a general regulatory filing or a report announcement, but a specific disclosure of a financing event.
2024-07-31 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange. It specifically details a 'Correction Report' (정정신고) regarding the issuance of convertible bonds (전환사채권 발행결정), including changes to maturity dates and conversion terms. This falls under the category of capital structure and financing updates.
2024-07-15 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange). It specifically details a 'Correction Report' (정정신고) regarding the issuance of convertible bonds (전환사채권 발행결정), including changes to maturity dates and conversion terms. This falls under the category of capital structure and financing updates.
2024-07-15 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company, BioProtech, detailing a correction (정정신고) to a previously filed convertible bond issuance (전환사채권 발행결정). It outlines changes to the maturity date and associated terms (interest, conversion, and early redemption options). Since this is a formal regulatory filing regarding capital structure and financing terms, it falls under the 'Capital/Financing Update' category.
2024-07-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.